{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:21:05Z","timestamp":1787757665199,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In recent studies, it has been established that countries having Bacillus Calmette-Guerin (BCG) vaccination programs reported less COVID-19 cases and deaths per population Preliminary studies suggest that BCG vaccination could upregulate the vaccine-induced immunity against SARS-CoV-2. Hence, the recent study was aimed to determine the association of BCG vaccine with the development of COVID-19 in health care workers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The participants included in the study were healthcare workers (doctors, paramedics, and other supporting staff) working in the high and low-risk zones of COVID-19 in the hospital. The Graph Pad statistical analysis tool was used to determine the association of preliminary BCG vaccination with their COVID-19 status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 200 health care workers working in different departments of the hospital were enrolled in the study. The relative risk of COVID-19 positivity in BCG vaccinated versus unvaccinated was 0.79 (0.50\u20131.25). There was also a significant negative correlation between two groups. The relative risk of COVID-19 positivity in those with a BCG scar was 0.63 (0.44\u20130.92). The relative risk of COVID-19 infection in those with a history of tuberculosis was 1.08 (0.56\u20132.09).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present study did not support the beneficial effect of BCG vaccine in protection against the development of COVID-19 disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_179_21","type":"journal-article","created":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T15:14:06Z","timestamp":1639322046000},"page":"433-436","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Role of Bacillus Calmette\u2013Guerin Vaccination in Protection against COVID-19"],"prefix":"10.4103","volume":"10","author":[{"given":"Anil","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PVM","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20240902","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/bbrj.bbrj_138_20","article-title":"A multipronged strategy operationalized to combat the COVID-19 pandemic in India","volume":"4","author":"Bhatia","year":"2020","journal-title":"Biomed Biotechnol Res J"},{"key":"R2-14-20240902","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/all.14345","article-title":"Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","volume":"75","author":"Gursel","year":"2020","journal-title":"Allergy"},{"key":"R3-14-20240902","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/all.14344","article-title":"Is BCG vaccination affecting the spread and severity of COVID-19?","volume":"75","author":"Ozdemir","year":"2020","journal-title":"Allergy"},{"key":"R4-14-20240902","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"R5-14-20240902","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"key":"R6-14-20240902","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-14-20240902","doi-asserted-by":"crossref","first-page":"25205","DOI":"10.1073\/pnas.2015234117","article-title":"The bacillus Calmette-Gu\u00e9rin vaccination allows the innate immune system to provide protection from severe COVID-19 infection","volume":"117","author":"Patella","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-14-20240902","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: Randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"R10-14-20240902","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1542\/peds.112.4.e298","article-title":"A prospective study of bacillus calmette-gu\u00e9rin scar formation and tuberculin skin test reactivity in infants in Lima, Peru","volume":"112","author":"Santiago","year":"2003","journal-title":"Pediatrics"},{"key":"R11-14-20240902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2212-5531.307058","article-title":"Is the BCG vaccination effective against COVID-19?","volume":"10","author":"Velayati","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R12-14-20240902","first-page":"123","article-title":"Cell medicated immunity in children with scar-failure following BCG vaccination","volume":"35","author":"Rani","year":"1998","journal-title":"Indian Pediatr"},{"key":"R13-14-20240902","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R15-14-20240902","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/ijmy.ijmy_86_21","article-title":"Bacillus Calmette-Guerin as a quick and temporary solution to coronavirus disease-2019","volume":"10","author":"Kumari","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R16-14-20240902","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 An update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"R17-14-20240902","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol"},{"key":"R19-14-20240902","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/ijmy.ijmy_56_21","article-title":"Drug-resistant tuberculosis and COVID-19 co-infection: A systematic review of case reports","volume":"10","author":"Ortiz-Mart\u00ednez","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R20-14-20240902","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/ijmy.ijmy_51_21","article-title":"COVID-19 pneumonia with pulmonary tuberculosis: Double trouble","volume":"10","author":"Patil","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R21-14-20240902","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/bbrj.bbrj_188_20","article-title":"Serum levels of interleukin-6, ferritin, C-reactive protein, lactate dehydrogenase, D-dimer, and count of lymphocytes and neutrophils in COVID-19 patients: Its correlation to the disease severity","volume":"5","author":"Kadhim","year":"2021","journal-title":"Biomed Biotechnol Res J"},{"key":"R22-14-20240902","doi-asserted-by":"crossref","first-page":"632478","DOI":"10.3389\/fimmu.2021.632478","article-title":"The BCG vaccine for COVID-19: First verdict and future directions","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"Front Immunol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_179_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:48:53Z","timestamp":1787755733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_179_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_179_21","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}